Melanotan I
A melanocortin peptide analogue tied to pigmentation and photoprotection research, and closely related to the approved drug afamelanotide.
Also referenced as: Afamelanotide, Scenesse
Also appears in: Hormone
This peptide maps to at least one regulated medical product or label context in the United States.
Primary lane: Skin & Cosmetic. Also surfaces under Hormone for browsing and discovery.
Afamelanotide, Scenesse
FDA label signal · 23 trials · 116 PubMed results
What melanotan I is
Melanotan I refers to a melanocortin peptide analogue better known clinically as afamelanotide. In regulated medicine, afamelanotide is the name that matters more than the older research-market shorthand.
Why it matters
It is one of the clearest examples of a peptide that sits across two different worlds: scientific and clinical development on one side, and aesthetic or tanning-oriented internet discussion on the other.
Regulatory context
Afamelanotide has FDA approval in the United States for a narrow labeled use. That does not mean all products sold under melanotan-style naming are equivalent to an approved medicine.
Practical reading note
This is a good reminder that a familiar peptide-market nickname can hide a very important distinction between approved pharmaceutical use and unregulated cosmetic-market interpretation.